Ethylpropyltryptamine

Ethylpropyltryptamine
Clinical data
Other namesEPT; N-Ethyl-N-propyltryptamine
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H22N2
Molar mass230.355 g·mol−1
3D model (JSmol)
  • CCCN(CC)CCC1=CNC2=CC=CC=C12
  • InChI=1S/C15H22N2/c1-3-10-17(4-2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3
  • Key:LCDYRMYSOIVPRS-UHFFFAOYSA-N

Ethylpropyltryptamine (EPT), also known as N-ethyl-N-propyltryptamine, is a rarely encountered psychedelic drug of the tryptamine family, which makes it structurally related to other psychedelic tryptamines including dimethyltryptamine (DMT), methylethyltryptamine (MET), diethyltryptamine (DET), dipropyltryptamine (DPT), and methylpropyltryptamine (MPT).

Interactions

[edit]

Society and culture

[edit]
[edit]

United Kingdom

[edit]

It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act of 2016.[1]

United States

[edit]

EPT is unscheduled but it may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption could be illegal under the Federal Analogue Act.

See also

[edit]

References

[edit]
[edit]